“Successful Benralizumab Therapy for Severe Asthma Secondary to EGPA Refractory to Mepolizumab”. Revista Alergia México 72, no. 3 (September 30, 2025): 216. Accessed September 23, 2026. https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1490.